Dealing with Drugs: Ethical, Legal, and Policy Issues - from the Opioid Epidemic to Budget-Busting Blockbuster Drugs
This program has been approved by the Pennsylvania Continuing Legal Education Board for (6) hours of substantive credit. There is a $200 fee for processing CLE credit for this event.
Drug use, particularly the opioid epidemic, threatens the health and well-being of entire regions, communities, families, and individuals. Addressing the epidemic requires action at multiple levels from individual provider practices to state and national policies. At each level, ethical and legal issues arise. Simultaneously, blockbuster (and budget busting) new drugs promise life-saving and quality-of life enhancing benefits to patients suffering from chronic and acute conditions, but threaten the fiscal viability of our healthcare system. The pharmaceutical industry’s social roles indeed raise ethical concerns about the health of our research and regulatory infrastructures and about transparency within the provider-patient relationship. This conference features three lectures in the morning with concurrent breakout sessions in the afternoon on ethical concerns regarding: substance using pregnant women, medical use of marijuana, conflicts of interest, adherence to cancer treatment, policy to guide valve replacement practices for patients with opioid use disorders, and pharmacogenomics.